Breaking News Instant updates and real-time market news.

2021-10-04 08:23:23 XLP Consumer Staples Sector SPDR $68.99 / +0.17 (+0.25%) 08:23 10/04/21 10/04 08:23 10/04/21 08:23	Consumer Staples Sector SPDR: Pivot points The following are the pivot points for the . Pivot High: $69.185, Pivot Low: $68.205. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low.

2021-10-04 08:23:23

XLP

Consumer Staples Sector SPDR

$68.99 / +0.17 (+0.25%)

08:23

10/04/21

10/04

08:23

10/04/21

08:23

Consumer Staples Sector SPDR: Pivot points

The following are the pivot points for the . Pivot High: $69.185, Pivot Low: $68.205. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks	Medtronic names Pfizer executive Lidia Fonseca as new director » 07:03 06/27/22 06/27 07:03 06/27/22 07:03 MDT Medtronic $90.21 / +1.545 (+1.74%) , PFE Pfizer $51.60 / +1.51 (+3.01%) Medtronic plc (MDT)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MDT PFE MDT Medtronic $90.21 / +1.545 (+1.74%) 06/13/22 IceCure Medical, Shanghai Medtronic, Turing Medical sign distribution agreement 05/26/22 Medtronic: Q1 EPS guidance includes FX headwind of about 5c 05/26/22 Medtronic: Procedure volumes in most markets reached pre-Covid levels by Q4E 05/26/22 Medtronic sees 'strong' improvement in 2H23, pipeline 'robust' PFE Pfizer $51.60 / +1.51 (+3.01%) 06/25/22 Pfizer, BioNTech announce data evaluating omicron-adapted vaccine candidates 06/23/22 Valneva says Pfizer to initiate Phase 3 study of VLA15 in third quarter 06/23/22 BioNTech starts construction on first mRNA vaccine facility in Africa 06/21/22 Enanta files patent infringement lawsuit against Pfizer MDT PFE MDT Medtronic $90.21 / +1.545 (+1.74%) 06/01/22 Atlantic Equities Medtronic downgraded to Neutral from Overweight at Atlantic Equities 05/31/22 Raymond James Medtronic price target lowered to $109 from $116 at Raymond James 05/31/22 Truist Medtronic price target lowered to $111 from $121 at Truist 05/27/22 RBC Capital Medtronic price target lowered to $122 from $135 at RBC Capital PFE Pfizer $51.60 / +1.51 (+3.01%) 06/22/22 Piper Sandler Enanta's lawsuit against Pfizer 'not surprising,' says Piper Sandler 06/13/22 Morgan Stanley Moderna pediatric EUA vaccine briefing docs 'clean,' says Morgan Stanley 06/03/22 Oppenheimer Turning Point Therapeutics downgraded to Perform from Outperform at Oppenheimer 05/31/22 Evercore ISI Enanta upgraded to In Line from Underperform at Evercore ISI MDT PFE MDT Medtronic $90.21 / +1.545 (+1.74%) 05/26/22 Medtronic sees Q1 organic revenue down 4.5%-5.5%, consensus $8.14B 05/26/22 Medtronic sees Q1 EPS $1.10-$1.14, consensus $1.40 05/26/22 Medtronic sees FY23 EPS $5.53-$5.65, consensus $5.82 05/26/22 Medtronic reports Q4 EPS $1.52, consensus $1.56 PFE Pfizer $51.60 / +1.51 (+3.01%) 05/03/22 Pfizer cuts FY22 adjusted EPS view to $6.25-$6.45 from $6.35-$6.55 05/03/22 Pfizer reports Q1 adjusted EPS $1.62, consensus $1.47 05/02/22 Notable companies reporting before tomorrow's open 05/02/22 Notable companies reporting before tomorrow's open MDT PFE MDT Medtronic $90.21 / +1.545 (+1.74%) 02/05/22 Medtronic stock can gain 20% as COVID subsides, Barron's says PFE Pfizer $51.60 / +1.51 (+3.01%) 06/23/22 Moderna vaccine for kids gets backing of CDC advisers, WSJ reports 06/12/22 Review says Pfizer vaccine works safely in young children, WSJ reports 06/02/22 Pfizer ask FDA to authorize three doses of vaccine for kids under 5, WSJ report 05/31/22 Pfizer's Paxlovid becomes leading pandemic pill, WSJ reports MDT PFE MDT Medtronic $90.21 / +1.545 (+1.74%) 06/01/22 What You Missed On Wall Street On Wednesday 06/01/22 What You Missed On Wall Street This Morning 06/01/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/27/22 What You Missed On Wall Street This Morning PFE Pfizer $51.60 / +1.51 (+3.01%) 06/21/22 What You Missed On Wall Street On Tuesday 06/21/22 What You Missed On Wall Street This Morning 06/21/22 Fly Intel: Pre-market Movers 06/17/22 What You Missed On Wall Street On Friday 07/14/22 Pharmaceuticals 07/14/22 Biotech/Biopharma 07/28/22 Pfizer - PFE 08/23/22 Medtronic - MDT 08/06/22 Extended PDUFA Date for MYFEMBREE MDT PFE MDT Medtronic $90.21 / +1.545 (+1.74%) 04/27/22 Medtronic put volume heavy and directionally bearish 01/31/22 Medtronic put volume heavy and directionally bearish PFE Pfizer $51.60 / +1.51 (+3.01%) 05/20/22 Early notable gainers among liquid option names on May 20th 04/26/22 Unusually active option classes on open April 26th 04/11/22 Unusually active option classes on open April 11th 04/07/22 Pfizer call volume above normal and directionally bullish
Downgrade	Bed Bath & Beyond downgraded to Neutral from Buy at B. Riley » 07:02 06/27/22 06/27 07:02 06/27/22 07:02 BBBY Bed Bath & Beyond $6.99 / -0.145 (-2.03%) B. Riley analyst Susan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BBBY Bed Bath & Beyond $6.99 / -0.145 (-2.03%) 06/23/22 Bed Bath & Beyond launches new savings program, Welcome Rewards 05/12/22 GameStop, AMC, Bed Bath & Beyond rise as 'meme stocks' see momentum 04/22/22 Bed Bath & Beyond trading resumes 04/22/22 Bed Bath & Beyond up 11% after WSJ report on buyout interest for baby unit BBBY Bed Bath & Beyond $6.99 / -0.145 (-2.03%) 06:50 Today Baird Bed Bath & Beyond price target lowered to $7 from $14 at Baird 06/22/22 BofA BofA cuts Bed Bath & Beyond target to $3, says buybuy BABY sale unlikely 06/22/22 Wedbush Bed Bath & Beyond price target lowered to $7 from $14 at Wedbush 06/22/22 UBS Bed Bath & Beyond price target lowered to $5 from $12 at UBS BBBY Bed Bath & Beyond $6.99 / -0.145 (-2.03%) 04/13/22 Bed Bath & Beyond reports Q4 adjusted EPS (92c), consensus 3c 04/12/22 Notable companies reporting before tomorrow's open 04/12/22 Notable companies reporting before tomorrow's open 01/06/22 Bed Bath & Beyond cuts FY21 adjusted EPS view to (15c)-0c from 70c-$1.10 BBBY Bed Bath & Beyond $6.99 / -0.145 (-2.03%) 04/22/22 Bed Bath & Beyond seeing interest from suitors for Buybuy Baby, WSJ says 04/22/22 Bed Bath & Beyond's Buybuy Baby seeing interest from suitors, WSJ says 03/25/22 Bed Bath near settlement with Cohen, to add three directors, Bloomberg reports 03/06/22 Chewy co-founder Ryan Cohen takes large stake in Bed Bath & Beyond, WSJ says BBBY Bed Bath & Beyond $6.99 / -0.145 (-2.03%) 04/22/22 What You Missed On Wall Street On Friday 04/14/22 What You Missed On Wall Street On Thursday 04/14/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/13/22 What You Missed On Wall Street On Wednesday 06/29/22 Bed Bath & Beyond - BBBY 07/14/22 Bed Bath & Beyond Inc. BBBY Bed Bath & Beyond $6.99 / -0.145 (-2.03%) 06/23/22 Bed Bath & Beyond call volume above normal and directionally bullish 06/21/22 Bed Bath & Beyond call volume above normal and directionally bullish 06/17/22 Bed Bath & Beyond call volume above normal and directionally bullish 06/02/22 Bed Bath & Beyond call volume above normal and directionally bullish
Hot Stocks	Farmers Edge announces departure of President Wortzman » 07:02 06/27/22 06/27 07:02 06/27/22 07:02 FMEGF Farmers Edge $1.92 / + (+0.00%) Farmers Edge announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research FMEGF Farmers Edge $1.92 / + (+0.00%) 04/05/22 Gevo, Farmers Edge partner to verify sustainable fuels FMEGF Farmers Edge $1.92 / + (+0.00%) 05/20/22 Raymond James Farmers Edge price target lowered to C$3.50 from C$4.50 at Raymond James 05/17/22 Canaccord Farmers Edge price target lowered to C$2.50 from C$3.50 at Canaccord 03/31/22 Canaccord Farmers Edge price target lowered to C$3.50 from C$4.50 at Canaccord 03/31/22 Raymond James Farmers Edge price target lowered to C$4.50 from C$6 at Raymond James
Upgrade	Chewy upgraded to Buy from Hold at Needham » 07:02 06/27/22 06/27 07:02 06/27/22 07:02 CHWY Chewy $38.24 / +1.59 (+4.34%) Needham analyst Anna… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CHWY Chewy $38.24 / +1.59 (+4.34%) 06/08/22 Chewy director Star buys $5.0M in common stock 06/02/22 Chewy rises 20.1% 06/02/22 Chewy rises 15.2% 06/02/22 Chewy rises 10.3% CHWY Chewy $38.24 / +1.59 (+4.34%) 06/21/22 Wedbush Wedbush upgrades Chewy to Outperform on favorable risk/reward 06/21/22 Wedbush Chewy upgraded to Outperform from Neutral at Wedbush 06/03/22 Wells Fargo Chewy price target lowered to $55 from $65 at Wells Fargo 06/02/22 Citi Chewy price target lowered to $29 from $45 at Citi CHWY Chewy $38.24 / +1.59 (+4.34%) 06/01/22 Chewy reports Q1 EPS 4c, consensus (14c) 06/01/22 Notable companies reporting after market close 03/29/22 Chewy sees FY22 revenue $10.2B-$10.4B, consensus $10.61B 03/29/22 Chewy sees Q1 revenue $2.40B-$2.43B, consensus $2.51B CHWY Chewy $38.24 / +1.59 (+4.34%) 05/28/22 Chewy earnings might not be so great but stock could take off, Barron's says 03/06/22 Chewy co-founder Ryan Cohen takes large stake in Bed Bath & Beyond, WSJ says CHWY Chewy $38.24 / +1.59 (+4.34%) 06/25/22 Short Report: Bears undeterred by bounce in growth names 06/21/22 Fly Insider: ABM, Box among week's notable inside trades 06/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/13/22 Fly Insider: Tela Bio, Airbnb among week's notable insider trades 06/28/22 4th Annual 07/14/22 Chewy, Inc. CHWY Chewy $38.24 / +1.59 (+4.34%) 06/03/22 Unusually active option classes on open June 3rd 06/02/22 Notable open interest changes for June 2nd 05/24/22 Chewy call volume above normal and directionally bullish 04/06/22 Chewy call volume above normal and directionally bullish
Hot Stocks	Nuvation Bio announces FDA partial hold for Phase 1 study of NUV-422 » 07:01 06/27/22 06/27 07:01 06/27/22 07:01 NUVB Nuvation Bio $4.17 / -0.055 (-1.30%) Nuvation Bio announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly NUVB Nuvation Bio $4.17 / -0.055 (-1.30%) 01/20/22 Nuvation Bio's IND application for NUV-868 in solid tumors cleared by FDA NUVB Nuvation Bio $4.17 / -0.055 (-1.30%) 05/04/22 H.C. Wainwright Nuvation Bio initiated with a Buy at H.C. Wainwright 03/22/22 BMO Capital Nuvation Bio price target lowered to $12 from $17 at BMO Capital 10/14/21 BTIG Nuvation Bio assumed with a Buy at BTIG NUVB Nuvation Bio $4.17 / -0.055 (-1.30%) 05/09/22 Nuvation Bio reports Q1 EPS (10c), consensus (14c) 02/28/22 Nuvation Bio reports Q4 EPS (12c), consensus (12c) NUVB Nuvation Bio $4.17 / -0.055 (-1.30%) 05/04/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations

Recommendations	FIS valuation compelling despite margin challenges, says Susquehanna » 06:58 06/27/22 06/27 06:58 06/27/22 06:58 FIS FIS $98.65 / +5.675 (+6.10%) Susquehanna analyst James… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options FIS FIS $98.65 / +5.675 (+6.10%) 06/07/22 FIS delivers derivatives solution to Societe Generale 05/16/22 Soros Capital buys Suncor and Mosaic during Q1, exits Alphabet 05/11/22 FIS announces new embedded finance offering in partnership with Treasury Prime 02/14/22 FIS announces acquisition of Atlanta-based, Payrix, terms undisclosed FIS FIS $98.65 / +5.675 (+6.10%) 06/13/22 Evercore ISI Evercore upgrades 'compelling' payments incumbent FIS to Outperform 06/13/22 Evercore ISI FIS upgraded to Outperform from In Line at Evercore ISI 05/17/22 Goldman Sachs FIS initiated with a Buy at Goldman Sachs 05/17/22 Mizuho FIS price target lowered to $130 from $135 at Mizuho FIS FIS $98.65 / +5.675 (+6.10%) 05/03/22 FIS sees FY22 EPS $7.25- $7.37, consensus $7.29 05/03/22 FIS l sees Q2 EPS $1.72-$1.75, consensus $1.75 05/03/22 FIS reports Q1 EPS $1.47, consensus $1.45 05/02/22 Notable companies reporting before tomorrow's open FIS FIS $98.65 / +5.675 (+6.10%) 06/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/03/22 Fly Intel: Pre-market Movers 02/15/22 What You Missed On Wall Street On Tuesday 02/15/22 What You Missed On Wall Street This Morning FIS FIS $98.65 / +5.675 (+6.10%) 01/05/22 Fidelity National Information Services call volume above normal and directionally bullish
Hot Stocks	McDonald's names Marion Gross as global chief supply chain officer 06:57 06/27/22 06/27 06:57 06/27/22 06:57 MCD McDonald's $247.85 / +4.24 (+1.74%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options MCD McDonald's $247.85 / +4.24 (+1.74%) 06:57 Today McDonald's names Kevin Ozan as SEVP, strategic initiatives, Ian Borden as CFO 06:56 Today McDonald's names Kevin Ozan as SEVP, strategic initiatives, Ian Borden as CFO 06/22/22 McDonald's, Adyen expand mobile app partnership to the U.S. 06/12/22 Fly Intel: Top five weekend stock stories MCD McDonald's $247.85 / +4.24 (+1.74%) 06/22/22 BTIG McDonald's franchisee checks suggest strength, says BTIG 06/09/22 Barclays McDonald's price target lowered to $289 from $300 at Barclays 06/07/22 UBS McDonald's should prove resilient in event of recession, says UBS 05/25/22 Truist McDonald's price target lowered to $273 from $280 at Truist MCD McDonald's $247.85 / +4.24 (+1.74%) 04/28/22 McDonald's reports Q1 adjusted EPS $2.28, consensus $2.17 04/27/22 Notable companies reporting before tomorrow's open 04/27/22 Notable companies reporting before tomorrow's open 01/27/22 McDonald's reports Q4 adjusted EPS $2.23, consensus $2.34 MCD McDonald's $247.85 / +4.24 (+1.74%) 06/23/22 McDonald's tightens restaurant ownership rules, WSJ reports 06/16/22 McDonald's to pay $1.3B to settle probes in France, Bloomberg reports 06/12/22 McDonald's in Russia reopens under new ownership, WSJ reports 06/05/22 Icahn drops proxy fight over pig treatment at Kroger, WSJ reports MCD McDonald's $247.85 / +4.24 (+1.74%) 06/16/22 What You Missed On Wall Street This Morning 05/19/22 What You Missed On Wall Street On Thursday 05/19/22 What You Missed On Wall Street This Morning 05/16/22 What You Missed On Wall Street On Monday MCD McDonald's $247.85 / +4.24 (+1.74%) 05/24/22 Early notable gainers among liquid option names on May 24th 04/28/22 Unusually active option classes on open April 28th 04/12/22 Unusually active option classes on open April 12th 04/08/22 Unusually active option classes on open April 8th
Hot Stocks	McDonald's names Kevin Ozan as SEVP, strategic initiatives, Ian Borden as CFO » 06:57 06/27/22 06/27 06:57 06/27/22 06:57 MCD McDonald's $247.85 / +4.24 (+1.74%) McDonald's… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options MCD McDonald's $247.85 / +4.24 (+1.74%) 06:56 Today McDonald's names Kevin Ozan as SEVP, strategic initiatives, Ian Borden as CFO 06/22/22 McDonald's, Adyen expand mobile app partnership to the U.S. 06/12/22 Fly Intel: Top five weekend stock stories 06/06/22 Carl Icahn to discontinue proxy contest waged at Kroger, withdraw nominees MCD McDonald's $247.85 / +4.24 (+1.74%) 06/22/22 BTIG McDonald's franchisee checks suggest strength, says BTIG 06/09/22 Barclays McDonald's price target lowered to $289 from $300 at Barclays 06/07/22 UBS McDonald's should prove resilient in event of recession, says UBS 05/25/22 Truist McDonald's price target lowered to $273 from $280 at Truist MCD McDonald's $247.85 / +4.24 (+1.74%) 04/28/22 McDonald's reports Q1 adjusted EPS $2.28, consensus $2.17 04/27/22 Notable companies reporting before tomorrow's open 04/27/22 Notable companies reporting before tomorrow's open 01/27/22 McDonald's reports Q4 adjusted EPS $2.23, consensus $2.34 MCD McDonald's $247.85 / +4.24 (+1.74%) 06/23/22 McDonald's tightens restaurant ownership rules, WSJ reports 06/16/22 McDonald's to pay $1.3B to settle probes in France, Bloomberg reports 06/12/22 McDonald's in Russia reopens under new ownership, WSJ reports 06/05/22 Icahn drops proxy fight over pig treatment at Kroger, WSJ reports MCD McDonald's $247.85 / +4.24 (+1.74%) 06/16/22 What You Missed On Wall Street This Morning 05/19/22 What You Missed On Wall Street On Thursday 05/19/22 What You Missed On Wall Street This Morning 05/16/22 What You Missed On Wall Street On Monday MCD McDonald's $247.85 / +4.24 (+1.74%) 05/24/22 Early notable gainers among liquid option names on May 24th 04/28/22 Unusually active option classes on open April 28th 04/12/22 Unusually active option classes on open April 12th 04/08/22 Unusually active option classes on open April 8th
Hot Stocks	AstraZeneca, Merck announce LYNPARZA receives positive opinion from CHMP » 06:57 06/27/22 06/27 06:57 06/27/22 06:57 AZN AstraZeneca $66.90 / +2.43 (+3.77%) , MRK Merck $93.22 / +1.14 (+1.24%) AstraZeneca (AZN) and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AZN MRK AZN AstraZeneca $66.90 / +2.43 (+3.77%) 06:18 Today AstraZeneca's Lynparza recommended for E.U. approval by CHMP in breast cancer 05:41 Today AstraZeneca, Daiichi Sankyo's Trastuzumab Deruxtecan recommended for approval 06/23/22 AstraZeneca reports detailed results from FoCus Phase 3 trial in Wilson disease 06/22/22 AstraZeneca, Biocartis enter agreement on companion diagnostic test for Tagrisso MRK Merck $93.22 / +1.14 (+1.24%) 06:18 Today AstraZeneca's Lynparza recommended for E.U. approval by CHMP in breast cancer 06/24/22 European Commission approves KEYTRUDA as adjuvant treatment for melanoma 06/24/22 Merck: EC approves KEYTRUDA for treatment of stage IIB or IIC melanoma 06/22/22 Merck says CDC panel votes to provisionally recommend use of Vaxneuvance AZN MRK AZN AstraZeneca $66.90 / +2.43 (+3.77%) 06/14/22 UBS AstraZeneca downgraded to Neutral from Buy at UBS 05/24/22 Danske Bank AstraZeneca initiated with a Buy at Danske Bank 05/18/22 Kepler Cheuvreux AstraZeneca downgraded to Hold from Buy at Kepler Cheuvreux 04/21/22 Morgan Stanley AstraZeneca price target raised to 11,100 GBp from 10,200 GBp at Morgan Stanley MRK Merck $93.22 / +1.14 (+1.24%) 06/24/22 Mizuho Merck deal would add 'novel and validated technology,' says Mizuho 06/21/22 Oppenheimer Seagen price target raised to $208 from $160 at Oppenheimer 04/12/22 Barclays Merck price target raised to $97 from $94 at Barclays 04/11/22 H.C. Wainwright Rubius Therapeutics price target lowered to $15 from $40 at H.C. Wainwright AZN MRK AZN AstraZeneca $66.90 / +2.43 (+3.77%) 04/29/22 AstraZeneca backs FY22 core EPS up by mid to high twenties percentage 04/29/22 AstraZeneca reports Q1 core EPS $1.89, up 20% y/y 02/10/22 AstraZeneca sees FY22 core EPS up by mid to high twenties percentage 02/10/22 AstraZeneca reports Q4 core EPS $1.67, two estimates 73c MRK Merck $93.22 / +1.14 (+1.24%) 04/28/22 Merck raises FY22 adjusted EPS view to $7.24-$7.36, consensus $7.24 04/28/22 Merck reports Q1 adjusted EPS $2.14, consensus $1.83 04/27/22 Notable companies reporting before tomorrow's open 04/27/22 Notable companies reporting before tomorrow's open AZN MRK AZN AstraZeneca $66.90 / +2.43 (+3.77%) 06/17/22 AstraZeneca considering bid for Mereo BioPharma, U.K. Times reports 05/10/22 Emergent plant's quality problems led to 400M discarded vaccines, WSJ reports 03/23/22 AstraZeneca preventive COVID shot set to win EU clearance, Reuters says MRK Merck $93.22 / +1.14 (+1.24%) 06/24/22 Merck moving forward with potential Seagen deal, WSJ reports 06/17/22 Merck, other suitors interested in acquiring Seagen, WSJ reports 06/17/22 Merck considering acquisition of Seagen, WSJ reports 05/31/22 Pfizer's Paxlovid becomes leading pandemic pill, WSJ reports AZN MRK AZN AstraZeneca $66.90 / +2.43 (+3.77%) 05/24/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/06/22 Fly Intel: Pre-market Movers 03/23/22 What You Missed On Wall Street On Wednesday 03/23/22 What You Missed On Wall Street This Morning MRK Merck $93.22 / +1.14 (+1.24%) 06/24/22 What You Missed On Wall Street On Friday 06/24/22 What You Missed On Wall Street This Morning 06/24/22 Fly Intel: Pre-market Movers 06/17/22 What You Missed On Wall Street On Friday 07/28/22 Merck - MRK 07/01/22 Extended PDUFA Date for Vaxneuvance 01/29/23 PDUFA Date for new sBLA for KEYTRUDA 10/04/22 Merck AZN MRK AZN AstraZeneca $66.90 / +2.43 (+3.77%) 06/06/22 Unusually active option classes on open June 6th 04/26/22 AstraZeneca call volume above normal and directionally bullish 04/07/22 AstraZeneca put volume heavy and directionally bearish 03/03/22 AstraZeneca put volume heavy and directionally bearish MRK Merck $93.22 / +1.14 (+1.24%) 06/01/22 Merck put volume heavy and directionally bearish 05/31/22 Merck put volume heavy and directionally bearish 05/18/22 Merck put volume heavy and directionally bearish 04/04/22 Merck call buyer realizes 64% same-day gains
Upgrade	Simply Good Foods upgraded to Overweight from Equal Weight at Stephens » 06:56 06/27/22 06/27 06:56 06/27/22 06:56 SMPL Simply Good Foods $38.81 / +0.45 (+1.17%) Stephens analyst Ben… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SMPL Simply Good Foods $38.81 / +0.45 (+1.17%) 04/13/22 Simply Good Foods announces $50M addition to share repurchase program SMPL Simply Good Foods $38.81 / +0.45 (+1.17%) 05/19/22 Mizuho Mizuho recommends buying three food stocks on recent selloff 04/07/22 Goldman Sachs Simply Good Foods price target raised to $50 from $45 at Goldman Sachs 04/07/22 Stephens Simply Good Foods price target raised to $44 from $41 at Stephens 04/07/22 Deutsche Bank Simply Good Foods price target raised to $48 from $45 at Deutsche Bank SMPL Simply Good Foods $38.81 / +0.45 (+1.17%) 04/06/22 Simply Good Foods raises 2022 net sales view up 13%-15% from up 12%-14% 04/06/22 Simply Good Foods reports Q2 adjusted EPS 36c, consensus 27c 01/05/22 Simply Good Foods expects 2022 net sales to increase 12%-14% vs. 2021 01/05/22 Simply Good Foods reports Q1 adjusted EPS 43c, consensus 34c SMPL Simply Good Foods $38.81 / +0.45 (+1.17%) 04/06/22 What You Missed On Wall Street On Wednesday 04/06/22 What You Missed On Wall Street This Morning 04/06/22 Fly Intel: Pre-market Movers 03/30/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/30/22 Simply Good Foods - SMPL

Hot Stocks	McDonald's names Kevin Ozan as SEVP, strategic initiatives, Ian Borden as CFO 06:56 06/27/22 06/27 06:56 06/27/22 06:56 MCD McDonald's $247.85 / +4.24 (+1.74%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options MCD McDonald's $247.85 / +4.24 (+1.74%) 06/22/22 McDonald's, Adyen expand mobile app partnership to the U.S. 06/12/22 Fly Intel: Top five weekend stock stories 06/06/22 Carl Icahn to discontinue proxy contest waged at Kroger, withdraw nominees 05/26/22 McDonald's shareholders re-elect all 12 directors at annual meeting MCD McDonald's $247.85 / +4.24 (+1.74%) 06/22/22 BTIG McDonald's franchisee checks suggest strength, says BTIG 06/09/22 Barclays McDonald's price target lowered to $289 from $300 at Barclays 06/07/22 UBS McDonald's should prove resilient in event of recession, says UBS 05/25/22 Truist McDonald's price target lowered to $273 from $280 at Truist MCD McDonald's $247.85 / +4.24 (+1.74%) 04/28/22 McDonald's reports Q1 adjusted EPS $2.28, consensus $2.17 04/27/22 Notable companies reporting before tomorrow's open 04/27/22 Notable companies reporting before tomorrow's open 01/27/22 McDonald's reports Q4 adjusted EPS $2.23, consensus $2.34 MCD McDonald's $247.85 / +4.24 (+1.74%) 06/23/22 McDonald's tightens restaurant ownership rules, WSJ reports 06/16/22 McDonald's to pay $1.3B to settle probes in France, Bloomberg reports 06/12/22 McDonald's in Russia reopens under new ownership, WSJ reports 06/05/22 Icahn drops proxy fight over pig treatment at Kroger, WSJ reports MCD McDonald's $247.85 / +4.24 (+1.74%) 06/16/22 What You Missed On Wall Street This Morning 05/19/22 What You Missed On Wall Street On Thursday 05/19/22 What You Missed On Wall Street This Morning 05/16/22 What You Missed On Wall Street On Monday MCD McDonald's $247.85 / +4.24 (+1.74%) 05/24/22 Early notable gainers among liquid option names on May 24th 04/28/22 Unusually active option classes on open April 28th 04/12/22 Unusually active option classes on open April 12th 04/08/22 Unusually active option classes on open April 8th
Hot Stocks	Sitio Royalties announces it completes acquisitions of 31,900 NRAs » 06:55 06/27/22 06/27 06:55 06/27/22 06:55 STR Sitio Royalties $23.13 / +0.62 (+2.75%) Sitio Royalties announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Options STR Sitio Royalties $23.13 / +0.62 (+2.75%) 06/07/22 Desert Peak Minerals, Falcon Minerals complete merger, creating Sitio Royalties STR Sitio Royalties $23.13 / +0.62 (+2.75%) 06/15/22 Credit Suisse Credit Suisse upgrades Sitio to Outperform, names new Top Pick in royalties 06/15/22 Credit Suisse Sitio Royalties upgraded to Outperform from Neutral at Credit Suisse STR Sitio Royalties $23.13 / +0.62 (+2.75%) 06/06/22 Two new option listings and two option delistings on June 6th
Recommendations	CarMax valuation attractive for patient investors, says Baird » 06:54 06/27/22 06/27 06:54 06/27/22 06:54 KMX CarMax $98.44 / +6.68 (+7.28%) Baird analyst Craig… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options KMX CarMax $98.44 / +6.68 (+7.28%) 06/24/22 CarMax plans to open ten new locations in FY23 06/24/22 CarMax sold 427,257 units in Q1, down 5.5% from the prior year quarter 05/16/22 Tepper's Appaloosa buys two casinos in Q1, exits T-Mobile and GM 04/12/22 CarMax drops 5% to $98.05 after Q4 earnings miss estimates KMX CarMax $98.44 / +6.68 (+7.28%) 06/07/22 JPMorgan CarMax price target lowered to $105 from $110 at JPMorgan 05/16/22 Evercore ISI CarMax added to 'Tactical Outperform' list at Evercore ISI 05/02/22 Needham Needham starts CarMax at Hold amid increased spending on omni-channel strategy 05/02/22 Needham CarMax initiated with a Hold at Needham KMX CarMax $98.44 / +6.68 (+7.28%) 06/24/22 CarMax reports Q1 EPS $1.56, consensus $1.49 06/23/22 Notable companies reporting before tomorrow's open 06/23/22 Notable companies reporting before tomorrow's open 04/12/22 CarMax reports Q4 EPS 98c, consensus $1.25 KMX CarMax $98.44 / +6.68 (+7.28%) 02/26/22 Deere among quality companies doing business mostly in the U.S., Barron's says KMX CarMax $98.44 / +6.68 (+7.28%) 06/24/22 What You Missed On Wall Street On Friday 06/24/22 What You Missed On Wall Street This Morning 05/02/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/13/22 What You Missed On Wall Street On Wednesday 09/29/22 CarMax - KMX 06/28/22 CarMax Inc. KMX CarMax $98.44 / +6.68 (+7.28%) 04/12/22 Unusually active option classes on open April 12th
Recommendations	Stifel still sees value in Carnival despite 'drastically' cutting estimates » 06:52 06/27/22 06/27 06:52 06/27/22 06:52 CCL Carnival $10.87 / +1.22 (+12.65%) Stifel analyst Steven… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CCL Carnival $10.87 / +1.22 (+12.65%) 06/24/22 Carnival Cruise Line brand to reach nearly 110% occupancy in Q3, says CEO 06/24/22 Carnival CEO says 'aggressively, yet thoughtfully ramping up to full operations' 06/24/22 Carnival reports Q2 occupancy 69%, up from 54% in Q1 06/24/22 Carnival provides update on bookings CCL Carnival $10.87 / +1.22 (+12.65%) 06:47 Today Wells Fargo Carnival price target lowered to $13 from $21 at Wells Fargo 06/21/22 Deutsche Bank Carnival price target lowered to $14 from $24 at Deutsche Bank 06/14/22 HSBC Carnival price target lowered to $7.70 from $18.20 at HSBC 06/09/22 Susquehanna Carnival initiated with a Neutral at Susquehanna CCL Carnival $10.87 / +1.22 (+12.65%) 06/24/22 Carnival expects a net loss for Q3 06/24/22 Carnival reports Q2 EPS ($1.61), consensus ($1.08) 06/23/22 Notable companies reporting before tomorrow's open 06/23/22 Notable companies reporting before tomorrow's open CCL Carnival $10.87 / +1.22 (+12.65%) 06/13/22 Carnival CEO tells Bloomberg company is 'recession resilient' 05/24/22 Carnival in talks to sell Seabourn to Saudi fund, CNBC's Mody reports 03/02/22 Carnival, Norwegian update mask policy, now optional for most, WSJ reports 01/07/22 Royal Caribbean, Norwegian Cruise cancel trips due to omicron, Reuters reports CCL Carnival $10.87 / +1.22 (+12.65%) 06/24/22 What You Missed On Wall Street On Friday 06/24/22 What You Missed On Wall Street This Morning 06/17/22 Bet On It: Maryland governor calls for online sports betting timeline 05/24/22 What You Missed On Wall Street On Tuesday CCL Carnival $10.87 / +1.22 (+12.65%) 06/24/22 Early notable gainers among liquid option names on June 24th 05/26/22 Notable open interest changes for May 26th 05/25/22 Unusually active option classes on open May 25th 05/25/22 Notable open interest changes for May 25th
Hot Stocks	Bright Minds Biosciences names Jan Torleif Pedersen as interim CSO » 06:52 06/27/22 06/27 06:52 06/27/22 06:52 DRUG Bright Minds Biosciences / + Bright Minds Biosciences… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News DRUG Bright Minds Biosciences / + 03/14/22 Bright Minds Biosciences says no major toxicological findings from BMB-101 study

Downgrade	Alnylam downgraded to Neutral from Buy at Guggenheim » 06:51 06/27/22 06/27 06:51 06/27/22 06:51 ALNY Alnylam $147.57 / +1.375 (+0.94%) Guggenheim analyst Debjit… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ALNY Alnylam $147.57 / +1.375 (+0.94%) 06/13/22 Alnylam announces FDA approval of AMVUTTRA 06/09/22 Alnylam Regeneron reports results from Phase 2 study of cemdisiran 06/02/22 Alnylam: C16-siRNA led to potent, durable knockdown in CNS, behavioral deficits 06/01/22 ProQR Therapeutics provides leadership updates ALNY Alnylam $147.57 / +1.375 (+0.94%) 06:30 Today Guggenheim Alnylam downgraded to Neutral from Buy at Guggenheim 06/21/22 Piper Sandler Ionis told Piper eplontersen efficacy competitive with Amvuttra 06/15/22 Citi Citi opens positive '90-day Catalyst Watch' Alnylam after approval 06/14/22 Piper Sandler Piper bullish on Alnylam as FDA approves AMVUTTRA for hATTR Polyneuropathy ALNY Alnylam $147.57 / +1.375 (+0.94%) 04/28/22 Alnylam reports Q1 EPS ($2.00), consensus ($1.84) 02/10/22 Alnylam reports Q4 EPS ($1.69), consensus ($1.54) 02/10/22 Alnylam reports Q4 EPS ($1.69), consensus ($1.54) 01/09/22 Alnylam sees preliminary FY21 combined product revenues $662M ALNY Alnylam $147.57 / +1.375 (+0.94%) 06/07/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/17/22 What You Missed On Wall Street On Thursday 03/17/22 What You Missed On Wall Street This Morning 01/21/22 Fly Intel: Pre-market Movers 07/14/22 Extended PDUFA Date for Vutrisiran 10/06/22 PDUFA Date for Oxlumo (Lumasiran)
Initiation	Deckers Brands resumed with an Equal Weight at Wells Fargo » 06:51 06/27/22 06/27 06:51 06/27/22 06:51 DECK Deckers Brands $273.32 / +11.79 (+4.51%) Wells Fargo analyst Kate… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly DECK Deckers Brands $273.32 / +11.79 (+4.51%) 06/10/22 Deckers Brands COO David Lafitte to step down 06/10/22 Deckers Brands names Angela Ogbechie as Chief Supply Chain Officer 06/09/22 Sanuk, Grateful Dead announce sixth iteration of ongoing collaboration 05/20/22 Deckers Brands rises 11.7% DECK Deckers Brands $273.32 / +11.79 (+4.51%) 05/20/22 BTIG Demand for Deckers brands UGG/HOKA 'not skipping a beat', says BTIG 05/20/22 Cowen Deckers Brands price target raised to $407 from $358 at Cowen 05/20/22 Stifel Deckers Brands price target raised to $338 from $315 at Stifel 05/20/22 Baird Deckers Brands price target lowered to $375 from $525 at Baird DECK Deckers Brands $273.32 / +11.79 (+4.51%) 05/19/22 Deckers Brands sees FY23 EPS $17.40-$18.25, consensus $18.34 05/19/22 Deckers Brands reports Q4 EPS $2.51, consensus $1.32 05/19/22 Notable companies reporting after market close 02/03/22 Deckers Brands reports Q3 EPS $8.42, consensus $8.19 DECK Deckers Brands $273.32 / +11.79 (+4.51%) 05/20/22 What You Missed On Wall Street On Friday 05/20/22 What You Missed On Wall Street This Morning 05/20/22 Fly Intel: Pre-market Movers 05/19/22 Fly Intel: After-Hours Movers
Hot Stocks	Genesco appoints Gregory Sandfort as lead independent director » 06:51 06/27/22 06/27 06:51 06/27/22 06:51 GCO Genesco $56.64 / +2.46 (+4.54%) Genesco Inc. announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings GCO Genesco $56.64 / +2.46 (+4.54%) 03/10/22 Genesco rises 11.4% 01/10/22 Genesco reports Q4 QTD sales up 18% GCO Genesco $56.64 / +2.46 (+4.54%) 03/10/22 CL King Genesco's competitive moat more evident than ever, says CL King 01/18/22 Seaport Global Seaport lists Nike, Foot Locker among Buys in Apparel/Footwear sector 01/18/22 Seaport Global Genesco initiated with a Buy at Seaport Global 11/30/21 Jefferies Genesco assumed with a Hold at Jefferies GCO Genesco $56.64 / +2.46 (+4.54%) 05/26/22 Genesco backs FY23 adjusted EPS $7.00-$7.75, consensus $7.41 05/26/22 Genesco reports Q1 adjusted EPS 44c, consensus (9c) 03/10/22 Genesco sees FY23 adjusted EPS $7.00-$7.75, consensus $7.13 03/10/22 Genesco reports Q4 EPS $3.48, consensus $2.64
Recommendations	Bed Bath & Beyond price target lowered to $7 from $14 at Baird » 06:50 06/27/22 06/27 06:50 06/27/22 06:50 BBBY Bed Bath & Beyond $6.99 / -0.145 (-2.03%) Baird analyst Justin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BBBY Bed Bath & Beyond $6.99 / -0.145 (-2.03%) 06/23/22 Bed Bath & Beyond launches new savings program, Welcome Rewards 05/12/22 GameStop, AMC, Bed Bath & Beyond rise as 'meme stocks' see momentum 04/22/22 Bed Bath & Beyond trading resumes 04/22/22 Bed Bath & Beyond up 11% after WSJ report on buyout interest for baby unit BBBY Bed Bath & Beyond $6.99 / -0.145 (-2.03%) 06/22/22 BofA BofA cuts Bed Bath & Beyond target to $3, says buybuy BABY sale unlikely 06/22/22 Wedbush Bed Bath & Beyond price target lowered to $7 from $14 at Wedbush 06/22/22 UBS Bed Bath & Beyond price target lowered to $5 from $12 at UBS 05/17/22 B. Riley Bed Bath & Beyond price target lowered to $17 from $26 at B. Riley BBBY Bed Bath & Beyond $6.99 / -0.145 (-2.03%) 04/13/22 Bed Bath & Beyond reports Q4 adjusted EPS (92c), consensus 3c 04/12/22 Notable companies reporting before tomorrow's open 04/12/22 Notable companies reporting before tomorrow's open 01/06/22 Bed Bath & Beyond cuts FY21 adjusted EPS view to (15c)-0c from 70c-$1.10 BBBY Bed Bath & Beyond $6.99 / -0.145 (-2.03%) 04/22/22 Bed Bath & Beyond seeing interest from suitors for Buybuy Baby, WSJ says 04/22/22 Bed Bath & Beyond's Buybuy Baby seeing interest from suitors, WSJ says 03/25/22 Bed Bath near settlement with Cohen, to add three directors, Bloomberg reports 03/06/22 Chewy co-founder Ryan Cohen takes large stake in Bed Bath & Beyond, WSJ says BBBY Bed Bath & Beyond $6.99 / -0.145 (-2.03%) 04/22/22 What You Missed On Wall Street On Friday 04/14/22 What You Missed On Wall Street On Thursday 04/14/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/13/22 What You Missed On Wall Street On Wednesday 06/29/22 Bed Bath & Beyond - BBBY 07/14/22 Bed Bath & Beyond Inc. BBBY Bed Bath & Beyond $6.99 / -0.145 (-2.03%) 06/23/22 Bed Bath & Beyond call volume above normal and directionally bullish 06/21/22 Bed Bath & Beyond call volume above normal and directionally bullish 06/17/22 Bed Bath & Beyond call volume above normal and directionally bullish 06/02/22 Bed Bath & Beyond call volume above normal and directionally bullish
Hot Stocks	TCR2 Therapeutics names Eric Sullivan as CFO » 06:49 06/27/22 06/27 06:49 06/27/22 06:49 TCRR TCR2 Therapeutics $2.87 / +0.06 (+2.14%) TCR2 Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events TCRR TCR2 Therapeutics $2.87 / +0.06 (+2.14%) 01/12/22 TCR2 Therapeutics names Rosemary Harrison as Chief Business and Strategy Officer 01/04/22 TCR2 Therapeutics, Arbor establish collaboration for TRuc-T cell therapies TCRR TCR2 Therapeutics $2.87 / +0.06 (+2.14%) 05/19/22 H.C. Wainwright TCR2 Therapeutics price target lowered to $14 from $19 at H.C. Wainwright 05/12/22 Piper Sandler TCR2 Therapeutics price target lowered to $15 from $23 at Piper Sandler 03/22/22 Piper Sandler TCR2 Therapeutics price target lowered to $23 from $26 at Piper Sandler 01/19/22 Goldman Sachs TCR2 Therapeutics assumed with Neutral from Buy at Goldman Sachs TCRR TCR2 Therapeutics $2.87 / +0.06 (+2.14%) 05/12/22 TCR2 Therapeutics reports Q1 EPS (76c), consensus (74c) 03/22/22 TCR2 Therapeutics reports Q4 EPS (72c), consensus (75c) 00:00 Today Truist Securities Cell Therapy Symposium: Symposia-cel

Recommendations	Celanese price target lowered to $180 from $200 at Wells Fargo » 06:49 06/27/22 06/27 06:49 06/27/22 06:49 CE Celanese $127.55 / +7.18 (+5.96%) Wells Fargo analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CE Celanese $127.55 / +7.18 (+5.96%) 05/25/22 Celanese announces acetyl intermediate price increases 05/16/22 Berkshire Hathaway adds Citi, exits Wells Fargo in Q1 05/11/22 Celanese declares Force Majeure on acetyl chain and acetate two products 03/31/22 Celanese sees EPS accretion from KEP restructuring 15-20c over three years CE Celanese $127.55 / +7.18 (+5.96%) 06:16 Today Credit Suisse Celanese initiated with an Underperform at Credit Suisse 06/16/22 Jefferies Celanese downgraded to Hold from Buy at Jefferies 05/18/22 Piper Sandler Celanese price target raised to $145 from $140 at Piper Sandler 04/13/22 Fermium Research DuPont price target lowered to $78 from $87 at Fermium Research CE Celanese $127.55 / +7.18 (+5.96%) 04/28/22 Celanese sees FY22 adjusted EPS approaching FY21 adjusted EPS 04/28/22 Celanese reports Q1 adjusted EPS $5.54, consensus $4.52 01/27/22 Celanese sees FY22 EPS 'at least' $15.00, consensus $15.85 01/27/22 Celanese sees Q1 EPS $4.30-$4.60, consensus $4.19 CE Celanese $127.55 / +7.18 (+5.96%) 02/17/22 Celanese near deal to buy DuPont materials unit for over $10B, Bloomberg says 02/17/22 Celanese near deal to buy DuPont materials unit for over $10B, Bloomberg says CE Celanese $127.55 / +7.18 (+5.96%) 06/16/22 What You Missed On Wall Street On Thursday 06/16/22 What You Missed On Wall Street This Morning 06/16/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/22/22 What You Missed On Wall Street On Tuesday CE Celanese $127.55 / +7.18 (+5.96%) 05/17/22 Early notable gainers among liquid option names on May 17th 04/29/22 Early notable gainers among liquid option names on April 29th
Hot Stocks	BWX executes commercial agreement with Bayer for supply of Actinium-225 » 06:47 06/27/22 06/27 06:47 06/27/22 06:47 BWXT BWX Technologies $53.17 / +2.635 (+5.21%) , BAYRY Bayer $15.23 / -0.15 (-0.98%) BWX Technologies (BWXT)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly BWXT BAYRY BWXT BWX Technologies $53.17 / +2.635 (+5.21%) 06/13/22 BWX Medical, TRIUMF execute licensing and services agreement 06/09/22 BWX Technologies to build first advanced nuclear microreactor in U.S. 05/03/22 BWX Technologies names Jan Bertsch chair of the board 05/03/22 BWX Technologies names Jan Bertsch chair of the board BAYRY Bayer $15.23 / -0.15 (-0.98%) 05/24/22 Senti Bio secures additional financing from Leaps by Bayer 05/19/22 Atara provides update on Bayer collaboration 05/10/22 Bayer confirms outlook for 2022 05/04/22 Bayer reports FDA accepts sNDA and grants priority review for Nubeqa combo BWXT BAYRY BWXT BWX Technologies $53.17 / +2.635 (+5.21%) 03/16/22 BofA BWX Technologies price target raised to $65 from $55 at BofA 12/14/21 Maxim BWX Technologies price target lowered to $65 from $68 at Maxim 11/17/21 Maxim BWX Technologies price target lowered to $68 from $77 at Maxim 11/02/21 Truist BWX Technologies price target lowered to $70 from $77 at Truist BAYRY Bayer $15.23 / -0.15 (-0.98%) 06/13/22 Redburn FMC downgraded to Neutral on cost inflation at Redburn 05/19/22 UBS Bayer price target raised to EUR 96 from EUR 90 at UBS 05/11/22 Barclays Bayer price target raised to EUR 90 from EUR 85 at Barclays 05/11/22 Credit Suisse Bayer price target raised to EUR 62 from EUR 56 at Credit Suisse BWXT BAYRY BWXT BWX Technologies $53.17 / +2.635 (+5.21%) 05/09/22 BWX Technologies backs FY22 adjusted EPS $3.05-$3.25, consensus $3.14 05/09/22 BWX Technologies reports Q1 adjusted EPS 69c, consensus 67c 02/22/22 BWX Technologies sees FY22 adjusted EPS $3.05-$3.25, consensus $3.12 02/22/22 BWX Technologies reports Q4 adjusted EPS 95c, consensus 93c BAYRY Bayer $15.23 / -0.15 (-0.98%) 05/10/22 Bayer reports Q1 core EPS EUR 3.53 vs. EUR 2.59 last year 03/01/22 Bayer sees 2022 group sales of EUR 47B 03/01/22 Bayer reports Q4 core EPS EUR 1.26 vs. EUR 1.32 last year BAYRY BAYRY Bayer $15.23 / -0.15 (-0.98%) 06/21/22 Supreme Court rejects Bayer bid to end Roundup suits, Bloomberg reports 05/11/22 Biden administration asks Supreme Court to reject Roundup appeal, Reuters says BAYRY BAYRY Bayer $15.23 / -0.15 (-0.98%) 06/21/22 What You Missed On Wall Street On Tuesday 06/21/22 What You Missed On Wall Street This Morning 05/11/22 What You Missed On Wall Street On Wednesday 05/11/22 What You Missed On Wall Street This Morning
Recommendations	Carnival price target lowered to $13 from $21 at Wells Fargo » 06:47 06/27/22 06/27 06:47 06/27/22 06:47 CCL Carnival $10.87 / +1.22 (+12.65%) Wells Fargo analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CCL Carnival $10.87 / +1.22 (+12.65%) 06/24/22 Carnival Cruise Line brand to reach nearly 110% occupancy in Q3, says CEO 06/24/22 Carnival CEO says 'aggressively, yet thoughtfully ramping up to full operations' 06/24/22 Carnival reports Q2 occupancy 69%, up from 54% in Q1 06/24/22 Carnival provides update on bookings CCL Carnival $10.87 / +1.22 (+12.65%) 06/21/22 Deutsche Bank Carnival price target lowered to $14 from $24 at Deutsche Bank 06/14/22 HSBC Carnival price target lowered to $7.70 from $18.20 at HSBC 06/09/22 Susquehanna Carnival initiated with a Neutral at Susquehanna 06/08/22 Morgan Stanley Carnival price target lowered to $13 from $17 at Morgan Stanley CCL Carnival $10.87 / +1.22 (+12.65%) 06/24/22 Carnival expects a net loss for Q3 06/24/22 Carnival reports Q2 EPS ($1.61), consensus ($1.08) 06/23/22 Notable companies reporting before tomorrow's open 06/23/22 Notable companies reporting before tomorrow's open CCL Carnival $10.87 / +1.22 (+12.65%) 06/13/22 Carnival CEO tells Bloomberg company is 'recession resilient' 05/24/22 Carnival in talks to sell Seabourn to Saudi fund, CNBC's Mody reports 03/02/22 Carnival, Norwegian update mask policy, now optional for most, WSJ reports 01/07/22 Royal Caribbean, Norwegian Cruise cancel trips due to omicron, Reuters reports CCL Carnival $10.87 / +1.22 (+12.65%) 06/24/22 What You Missed On Wall Street On Friday 06/24/22 What You Missed On Wall Street This Morning 06/17/22 Bet On It: Maryland governor calls for online sports betting timeline 05/24/22 What You Missed On Wall Street On Tuesday CCL Carnival $10.87 / +1.22 (+12.65%) 06/24/22 Early notable gainers among liquid option names on June 24th 05/26/22 Notable open interest changes for May 26th 05/25/22 Unusually active option classes on open May 25th 05/25/22 Notable open interest changes for May 25th
Initiation	Blueprint Medicines initiated with an Underweight at Wells Fargo » 06:47 06/27/22 06/27 06:47 06/27/22 06:47 BPMC Blueprint Medicines $60.12 / +3.75 (+6.65%) Wells Fargo analyst Derek… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly BPMC Blueprint Medicines $60.12 / +3.75 (+6.65%) 06/09/22 Blueprint Medicines provides updates on AYVAKIT/AYVAKYT program in SM 05/02/22 Roivant Sciences announces collaborations in targeted protein degradation 04/08/22 Blueprint Medicines says SYMPHONY results support development expansion 03/25/22 Blueprint Medicines' AYVAKYT receives EC approval for expanded indication BPMC Blueprint Medicines $60.12 / +3.75 (+6.65%) 06/14/22 Morgan Stanley Blueprint Medicines price target lowered to $65 from $92 at Morgan Stanley 06/09/22 Citi Citi downgrades Blueprint to Sell on Ayvakit market concerns 06/09/22 Citi Blueprint Medicines downgraded to Sell from Neutral at Citi 06/03/22 Wedbush Wedbush downgrades Turning Point, says deal positive for small/mid-cap biotechs BPMC Blueprint Medicines $60.12 / +3.75 (+6.65%) 05/03/22 Blueprint Medicines sees FY22 revenue $180M-$200M, consensus $192.34M 05/03/22 Blueprint Medicines reports Q1 EPS ($1.79), consensus ($1.86) 02/16/22 Blueprint Medicines sees 2022 revenue $180M-$200M, consensus $210.91M 02/16/22 Blueprint Medicines reports Q4 EPS ($5.40), consensus ($1.65) BPMC Blueprint Medicines $60.12 / +3.75 (+6.65%) 06/09/22 What You Missed On Wall Street On Thursday 06/09/22 What You Missed On Wall Street This Morning 06/01/22 What You Missed On Wall Street On Wednesday 06/01/22 What You Missed On Wall Street This Morning
Initiation	Eve Holding initiated with a Neutral at BTIG » 06:46 06/27/22 06/27 06:46 06/27/22 06:46 EVEX Eve Holding $6.31 / +0.135 (+2.19%) BTIG analyst Marvin Fong… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News On The Fly EVEX Eve Holding $6.31 / +0.135 (+2.19%) 06/10/22 Eve Holding rises 7.4% 06/07/22 Eve Holding rises 17.3% 05/31/22 Eve Holding partners with Porsche consulting on eVTOL strategy 05/20/22 Eve Holding Inc trading resumes EVEX Eve Holding $6.31 / +0.135 (+2.19%) 05/19/22 Fly Intel: After-Hours Movers

Events

Earnings calls, analyst events, roadshows and more

RLAY
Today at 08:00

Relay Therapeutics Firm Sponsored Meetings

Virtual Meeting
THO
Today at 09:00

Thor Industries Firm Sponsored Meetings

Airstream Headquarters, Jackson Center, OH
Today at 09:00

Technology/EV Supply Chain Industry Meetings
QRTEA
Today at 09:30

Qurate Retail Firm Sponsored Meetings

Virtual Meeting
NPSNY
Today at 10:00

Naspers - NPSNY Conference Calls
Today at 10:00

Consumer Industry Meetings
DELL
Today at 10:30

Dell Technologies Inc. CL C Firm Sponsored Meetings
UTHR
Today at 10:30

United Therapeutics Corporation Firm Sponsored Meetings
ORGN
Today at 11:00

Origin Materials Inc. Firm Sponsored Meetings
NTAP
Today at 11:30

NetApp - NTAP Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	IE X IE Ivanhoe Electric IPO Managers: BMO Capital & Jefferies, JPMorgan, Raymond James, RBC Capital, Scotiabank $11.75-12.50 14.388M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TUYA X TUYA Tuya Secondary Managers: CICC, BofA, Morgan Stanley & CMBI $2.30 7.3M Shares
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Consumer Staples Sector SPDR: Pivot points

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access